Topic: Avandamet
Rosiglitazone is an anti-diabetic drug in the thiazolidinedione class of drugs. While blindness is also a possible effect of diabetes, which Rosiglitazone is intended to treat, an article in Canadian journal CMAJ has documented several occurrences and recommends discontinuation at the first ...
Meet David Pulman. From a quick read of the GlaxoSmithKline (GSK) web site, you can see he has a distinguished and responsible position - since...
Used alone or in combination with a sulfonylurea, metformin, or a sulfonylurea and metformin as an adjunct to diet and exercise for the management of type 2 (noninsulin-dependent) diabetes mellitus (NIDDM). May continue current dosage of the sulfonylurea, metformin hydrochloride, or a ...
Titrate in increments of one tablet (using the tablet strength at which therapy was initiated) daily at 2-week intervals until adequate blood glucose control is achieved or maximum daily dosage of 2 g of metformin hydrochloride and 10 mg of glipizide is ...
American Association of Clinical Endocrinologists American College of Cardiology American Diabetes Association American Heart Association Endocrine Society . FDA agrees with these organizations and is conducting a thorough investigation.. FDA and GlaxoSmithKline (GSK), the maker of rosiglitazone, have long recognized that use of ...
